These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7792129)

  • 41. Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children.
    Tsai HY; Huang LM; Chiu HH; Hsueh PR; Lee PI; Lu CY; Chiu TF; Lin HC; Lee CY
    J Microbiol Immunol Infect; 1998 Sep; 31(3):165-70. PubMed ID: 10496153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicenter comparison of cyclacillin and amoxicillin in the treatment of acute streptococcal pharyngitis.
    McLinn SE; Kaplan J; West N
    Clin Ther; 1983; 5(3):299-304. PubMed ID: 6342785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of group A streptococcal tonsillopharyngitis. 5 days cephalosporin is as effective as 10 days penicillin].
    Adam D; Scholz H; Helmerking M
    MMW Fortschr Med; 2001 May; 143(18):40. PubMed ID: 11387706
    [No Abstract]   [Full Text] [Related]  

  • 44. Macrolides in the management of streptococcal pharyngitis/tonsillitis.
    Tarlow MJ
    Pediatr Infect Dis J; 1997 Apr; 16(4):444-8. PubMed ID: 9109157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
    Balfour JA; Benfield P
    Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study.
    Skoog Ståhlgren G; Tyrstrup M; Edlund C; Giske CG; Mölstad S; Norman C; Rystedt K; Sundvall PD; Hedin K
    BMJ; 2019 Oct; 367():l5337. PubMed ID: 31585944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy.
    Schwartz RH; Wientzen RL; Pedreira F; Feroli EJ; Mella GW; Guandolo VL
    JAMA; 1981 Oct; 246(16):1790-5. PubMed ID: 6792379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Streptococcal pharyngitis therapy: comparison of cyclacillin, cephalexin, and potassium penicillin V.
    Stillerman M; Isenberg HD
    Antimicrob Agents Chemother (Bethesda); 1970; 10():270-6. PubMed ID: 5000259
    [No Abstract]   [Full Text] [Related]  

  • 49. 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group.
    Adam D; Hostalek U; Tröster K
    Infection; 1995; 23 Suppl 2():S83-6. PubMed ID: 8537138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New approaches to the treatment of group A streptococcal pharyngitis.
    Gerber MA; Tanz RR
    Curr Opin Pediatr; 2001 Feb; 13(1):51-5. PubMed ID: 11176244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of cefpodoxime in the prophylaxis of recurrent pharyngotonsillitis.
    Mora R; Salami A; Mora F; Cordone MP; Ottoboni S; Passali GC; Barbieri M
    Int J Pediatr Otorhinolaryngol; 2003 Dec; 67 Suppl 1():S225-8. PubMed ID: 14662201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimum treatment of streptococcal pharyngitis.
    Scaglione F; Demartini G; Arcidiacono MM; Pintucci JP
    Drugs; 1997 Jan; 53(1):86-97. PubMed ID: 9010650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study of efficacy, safety and dosage on cefpodoxime proxetil in pediatric infections].
    Hirosawa H; Ishikawa Y; Takahashi S; Matsuda H; Ichihashi H
    Jpn J Antibiot; 1989 Jul; 42(7):1498-504. PubMed ID: 2810726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cefpodoxime proxetil: a new, broad-spectrum, oral cephalosporin.
    Chocas EC; Paap CM; Godley PJ
    Ann Pharmacother; 1993 Nov; 27(11):1369-77. PubMed ID: 8286813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A clinical study on cefpodoxime proxetil dry syrup in pediatric infections].
    Wagatsuma Y; Takase A; Fukushima N; Ishikawa A; Takahashi S
    Jpn J Antibiot; 1989 Jul; 42(7):1464-70. PubMed ID: 2810722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections.
    Cox CE; Graveline JF; Luongo JM
    Drugs; 1991; 42 Suppl 3():41-50. PubMed ID: 1726207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of cefatrizine and erythromycin for pediatric ear, nose, and throat infections.
    Cremonesi G; Tarantino V; Stura M; Ciampini M
    Clin Ther; 1987; 9(3):263-6. PubMed ID: 3300988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical experience: respiratory tract. Trimethoprim-sulfamethoxazole versus penicillin G in the treatment of group A beta-hemolytic streptococcal pharyngitis and tonsillitis.
    Trickett PC; Dineen P; Mogabgab W
    J Infect Dis; 1973 Nov; 128():Suppl:693-5 p. PubMed ID: 4585968
    [No Abstract]   [Full Text] [Related]  

  • 59. Streptococcal tonsillitis in general practice. A comparison of cephalexin and penicillin therapy.
    Gau DW; Horn RF; Solomon RM; Johnson P; Leigh DA
    Practitioner; 1972 Feb; 208(244):276-81. PubMed ID: 4552568
    [No Abstract]   [Full Text] [Related]  

  • 60. Twice-daily oral penicillin for treatment of streptococcal pharyngitis: less is best.
    Bass JW; Person DA; Chan DS
    Pediatrics; 2000 Feb; 105(2):423-4. PubMed ID: 10654966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.